Ignite Creation Date:
2024-05-06 @ 6:10 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05563558
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2022-09-21
Brief Title:
Pembrolizumab Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer PEAPOD_FOS
Sponsor:
Fundacion Oncosur
Organization:
Fundacion Oncosur
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-21
First Submit QC Date:
September 29 2022
Study First Post Date:
2022-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-10
Last Update Post Date:
2024-06-11
Last Update Post Date Type:
ACTUAL